Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.746,49
0,39%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zynerba Pharmaceuticals Inc (ZYNE) Zynerba Pharmaceuticals Inc (ZYNE) Notizie

ZYNE

Zynerba Pharmaceuticals (ZYNE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZYNE
DataOraFonteTitoloSimboloCompagnia
09/02/202401:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
19/10/202322:48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
12/10/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202316:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314:00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202322:05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
29/09/202315:00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202314:00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/09/202322:15GlobeNewswire Inc.Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research SymposiumNASDAQ:ZYNEZynerba Pharmaceuticals Inc
05/09/202322:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202315:05Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202314:23Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
24/08/202323:23Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/08/202322:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202323:29Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202323:20Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202313:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202313:30PR Newswire (US)HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202322:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202322:05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces New Date for Reconvened Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202322:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202322:05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces Further Adjournment of Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
21/06/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
20/06/202313:00GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual ConferenceNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/06/202322:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZYNE

La tua Cronologia

NYSE
ED-A.CL
EU
BE2140869790
Euronext VPU Public auct...
BIT
I07566
INTESA SANPAOLO
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network